BioAmber clinches Lanxess funding, partners with NatureWorks to form AmberWorks

February 23, 2012 | Analyst Insight

BioAmber closed a Series C funding round for $30 million, with Lanxess participating in the latter of two tranches with $10 million and joining the BioAmber board. Existing investors Naxos...